|
SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and
... More »
 China Regulatory and Commercialization Backgrounder
Recent Releases
May 16, 2013
SciClone Reports Anticipated Financial Results for the First Quarter 2013
May 16, 2013
SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market
View all releases »
Events & Presentations
Jun 5, 2013 at 12:30 PM ET
Jefferies 2013 Global Healthcare Conference
Apr 1, 2013 at 4:30 PM ET
Q4 2012 SciClone Pharmaceuticals, Inc. Earnings
View all events & presentations »
|
| Stock Chart |
|
| Stock Quote |
| SciClone Pharmaceuticals, Inc. |
| Price: |
4.86 |
| Change: |
- 0.11 |
| Day High: |
4.93 |
| Day Low: |
4.78 |
| Volume: |
103,400 |
Delayed at least 20 minutes.
Provided by eSignal. |
|
